Cargando…
Leveraging Antisense Technology in the Lungs: RNA-Targeting Therapies for Respiratory Diseases
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122838/ https://www.ncbi.nlm.nih.gov/pubmed/32288508 http://dx.doi.org/10.1007/BF03257050 |
Ejemplares similares
-
Leveraging Technology to Improve Diabetes Care in Pregnancy
por: Crimmins, Sarah D., et al.
Publicado: (2020) -
How to leverage data security in a post-Covid world
por: Babbs, Andrea
Publicado: (2020) -
Leveraging the Code of Ethics to Practically Promote Ethics During COVID-19
por: Downs, Stuart, et al.
Publicado: (2022) -
The renaissance of RNA therapies
por: Gross, Michael
Publicado: (2021) -
Leveraging IoTs and Machine Learning for Patient Diagnosis and Ventilation Management in the Intensive Care Unit
Publicado: (2020)